Mycophenolic acid
Mycophenolic acid is a pharmaceutical drug with 19 clinical trials. Historical success rate of 73.3%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
2
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
73.3%
11 of 15 finished
26.7%
4 ended early
0
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Treg Modulation With CD28 and IL-6 Receptor Antagonists
Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation
Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
Clinical Trials (19)
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Treg Modulation With CD28 and IL-6 Receptor Antagonists
Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation
Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis
Crohn's Allogeneic Transplant Study
Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients
Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis
Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19